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ABSTRACT
Introduction: While anxiety is a major public health
problem in adults with arthritis and other rheumatic
diseases (AORD), the effects of exercise on anxiety in
adults are not well established despite numerous
studies on this topic. The purpose of this study is to
conduct a systematic review with an aggregate data
meta-analysis to determine the effects of community-
deliverable exercise interventions (aerobic, strength
training or both) on anxiety in adults with AORD.
Methods and analysis: Randomised controlled
exercise intervention trials ≥4 weeks and published in
any language up to 31 December 2016 will be
included. Studies will be retrieved by searching 8
electronic databases, cross-referencing and expert
review. Dual selection and abstraction of data will
occur. The primary outcome will be changes in anxiety.
Risk of bias will be assessed using the Cochrane risk
of bias assessment instrument while confidence in the
cumulative evidence will be assessed using the
Grading of Recommendations Assessment,
Development and Evaluation (GRADE) instrument.
Standardised effect sizes for anxiety will be calculated
from each study and then pooled using the inverse
variance heterogeneity (IVhet) model. Meta-regression
based on the IVhet model will be used to examine the
relationship between changes in anxiety and selected
covariates.
Dissemination: The results of this study will be
presented at a professional conference and published
in a peer-reviewed journal.
Trial registration number: CRD42016048728.
INTRODUCTION
Rationale
Arthritis and other rheumatic diseases
(AORD) are major public health problems in
the USA. Based on combined 2010–2012 data
from the National Health Interview Survey,
the annual prevalence of doctor-diagnosed
arthritis in the civilian, non-institutionalised
US population aged 18 years or older was
22.7% (52.5 million), with prevalence higher
among women (23.9%) than men (18.6%).1
By the year 2030, it is estimated that the preva-
lence of doctor-diagnosed arthritis in adults
aged 18 years and older will increase to ∼67
million.2 Compared with the combined 2010–
2012 data,1 this represents an increase of
∼14.5 million adults. Not surprisingly, the
financial costs associated with AORD in the
USA are high.1 In 2003, the total costs attrib-
utable to AORD were estimated to be ∼$128
billion, $80.8 billion in direct costs (medical
expenditures) and $47.0 billion in indirect
costs (lost earnings).3 This represents an
increase of 24% between 1997 and 2003.3
Elevated and sustained levels of anxiety
can result in a number of deleterious conse-
quences. These include, but are not limited
to: (1) an increased risk for coronary heart
disease as a result of heightened arousal
leading to an increased risk for hypertension
and a proinflammatory state,4–6 (2) an
Strengths and limitations of this study
▪ To the best of our knowledge, this is the first
systematic review with meta-analysis to use the
inverse variance heterogeneity model to examine
the effects of exercise on anxiety as a primary
outcome in adults with arthritis and other
rheumatic diseases (AORD).
▪ The results of this systematic review with
meta-analysis will be useful to practitioners for
making informed decisions about the role of
exercise in the treatment of anxiety in adults with
AORD as well as provide researchers with direc-
tion for the conduct and reporting of future
research on this topic.
▪ Common to most meta-analyses, the results may
yield significant heterogeneity which cannot be
explained.
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increased risk for cardiac death,5 (3) a poorer quality of
life,7 and (4) a poorer psychosocial functioning.7
While it is well recognised that depression is a
common comorbidity among adults with AORD, recent
research suggests that the prevalence of anxiety among
US adults with arthritis is approximately twice as high as
depression.8 Using data from the Arthritis Conditions
Health Effects Survey, the prevalence of anxiety and
depression among US adults with doctor-diagnosed arth-
ritis was estimated to be almost twice as high for anxiety
(30.5%) versus depression (17.5%), with US population
estimates of 11.5 million for anxiety and 6.6 million for
depression.8 Given the prevalence of anxiety, it was
recommended that healthcare providers screen people
with arthritis for anxiety.8
Exercise is an intervention that is generally safe and
appropriate for most persons with various types of
AORD.9 10 Recent meta-analytic work has shown that
community-deliverable exercise interventions reduce
depressive symptoms in adults, with an estimated 3.1
million inactive US adults with AORD improving their
depressive symptoms if they began and maintained a
regular exercise programme.11 However, the effects of
community-deliverable exercise on anxiety as a primary
outcome are not known given a plethora of conflicting
randomised controlled trials on this topic as well as a lack
of studies that assess both depression and anxiety within
the same study (only 44.8%).11 Most importantly, a
recent systematic review of previous meta-analyses, not to
be confused with an original systematic review with
meta-analyses, found that no meta-analysis of randomised
controlled trials has examined the effects of community-
deliverable exercise on anxiety as a primary outcome in
adults with AORD.12 Clearly, it is critically important to
develop a better understanding of the overall magnitude
of effect, as well as factors associated with exercise for
improving anxiety in adults with AORD.
Objective
The primary objective of this study is to conduct a sys-
tematic review with an aggregate data meta-analysis of
randomised controlled trials to determine the effects of
community-deliverable exercise interventions on anxiety
in adults with AORD.
METHODS
Overview
This study will follow the guidelines from the Preferred
Reporting Items for Systematic Reviews and Meta-Analysis
(PRISMA) statement for meta-analyses of healthcare
interventions13 and the current protocol report follows
the Preferred Reporting items for Systematic Review and
Meta-Analysis Protocols (PRISMA-P).14 15 This protocol is
registered in PROSPERO (trial registration number
CRD42016048728).
Eligibility criteria
Studies that meet the following criteria will be included:
(1) randomised controlled trials with the unit of assign-
ment at the participant level, (2) community-deliverable
exercise-only intervention group (aerobic, strength train-
ing or both), (3) interventions ≥4 weeks, (4) compara-
tive control group (non-intervention, wait-list control,
usual care, attention control), (5) adults ≥18 years of
age with doctor-diagnosed osteoarthritis, rheumatoid
arthritis or fibromyalgia, (6) studies (published and
unpublished in the form of Master’s theses and disserta-
tions) in any language, assuming an English language
abstract is available between 1 January 1981 and 31
December 2016, and (7) data for anxiety, as defined by
the authors of the original studies. Studies will be
limited to those with osteoarthritis, rheumatoid arthritis
or fibromyalgia based on our previous research showing
a lack of exercise intervention studies for other types of
AORD.11 Studies will be limited to randomised trials
because it is the only way to control for confounders
that are not known or measured as well as the observa-
tion that non-randomised controlled trials tend to over-
estimate the effects of healthcare interventions.16 17
Aerobic and progressive resistance (strength training)
exercise will be defined according to section C2 of the
2008 Physical Activity Guidelines Advisory Committee
Report.18 Specifically, aerobic exercise is defined as any
‘exercise that primarily uses the aerobic energy-
producing systems, can improve the capacity and effi-
ciency of these systems, and is effective for improving
cardiorespiratory endurance’, while strength training is
defined as ‘exercise training primarily designed to
increase skeletal muscle strength, power, endurance and
mass’.18
For this proposed project, community-deliverable exer-
cise interventions will be those that could be performed,
or have the potential to be adapted and performed, by
persons in a community setting (recreation or senior
centres, in the home or neighbourhood, etc.) and meet
the implementation guidelines for physical activity inter-
ventions recently recommended by the Arthritis
Program at the Centers for Disease Control and
Prevention: (1) no academic degree required for a
leader/implementer but leader training available, if
needed, (2) no special facilities beyond a community
room (except a warm pool for aquatic exercise), (3)
inexpensive equipment, (4) cost to participants <$50.00,
(5) implementation guide available, (6) supporting
structures judged to be adequate to support widespread
implementation.19 An exercise duration of at least
4 weeks was chosen based on previous research in which
statistically significant improvements in anxiety occurred
as a result of as little as 4 weeks of exercise training.20
There will be no maximum limit on the length of any
interventions for the studies included in our proposed
project. We will also limit our studies to adults aged
18 years and older because the inclusion of children and
adolescents poses additional confounding problems
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congruent with the many developmental changes that
occur during this period. In addition, the prevalence of
AORD is more common in adults than in children and
adolescents. We will restrict our studies to published arti-
cles, dissertations and Master’s theses and examine for
potential small-study effects such as publication bias
when limited to published articles in peer-reviewed jour-
nals. The year 1981 was chosen as the starting point for
eligibility based on a preliminary PubMed search in
which it was found that this was the first year that a ran-
domised controlled trial on exercise and arthritis was
published.21 Studies from both English and non-English
language sources will be included with the latter trans-
lated into English by the research technician using the
freely available web-based Babelfish and Bing translators.
For those studies that cannot be translated using
Babelfish and Bing, we will use professional translation
services to accomplish such translation. Finally, while
acknowledging that the mechanisms for changes in
anxiety may differ for different types of AORD, for
example, fibromyalgia versus osteoarthritis and rheuma-
toid arthritis, the purpose of the current systematic
review with meta-analysis is to determine whether exer-
cise reduces anxiety in adults with AORD, not why it
reduces anxiety.
Information sources
The following eight electronic databases will be searched
for potentially eligible studies in any language and pub-
lished between 1 January 1981 and 31 December 2016:
(1) PubMed, (2) SPORTDiscus, (3) Cochrane Central
Register of Controlled Clinical Trials (CENTRAL), (4)
Cumulative Index to Nursing and Allied Health
Literature (CINAHL), (5) PsychInfo, (6) Web of
Science, (7) Scopus and (8) ProQuest (Master’s theses
and dissertations). In addition, cross-referencing from
retrieved studies will be conducted. Furthermore, the
third author (LFC), an expert on exercise and AORD,
will review the reference list for completeness.
Search strategy
Search strategies will be developed using text words as
well as medical subject headings (MeSH) associated with
the effects of exercise on anxiety in adults with AORD.
Studies in languages other than English will be trans-
lated into the English language. The second author
(KSK) will conduct all electronic database searches. A
copy of a preliminary search strategy using PubMed,
including limits, can be found in online supplementary
file 1. This search strategy will be adapted for other data-
base searches.
Study records
Study selection
All studies to be screened will be imported into
EndNote (V.X8; EndNote (Version X8). New York, NY:
Thomson Reuters, 2016) and duplicates removed both
electronically and manually by the second author
(KSK). A copy of the database will then be provided to
the first author for duplicate screening. The first two
authors (GAK and KSK) will select all studies, independ-
ent of each other. The full report for each article will be
obtained for all titles and abstracts that appear to meet
the inclusion criteria or where there is any uncertainty.
Multiple reports of the same study will be handled by
including the most recently published article as well as
drawing from previous reports, assuming similar
methods and sample sizes. Neither of the screeners will
be blinded to the journal titles or to the study authors
or institutions. Reasons for exclusion will be coded as
one or more of the following: (1) inappropriate popula-
tion, (2) inappropriate intervention, (3) inappropriate
comparison(s), (4) inappropriate outcome(s), (5)
inappropriate study design and (6) other. On comple-
tion, the first two authors (GAK and KSK) will meet and
review their selections. Discrepancies will be resolved by
consensus. If consensus cannot be reached, the third
author (LFC) will provide a recommendation. The
overall agreement rate prior to correcting discrepant
items will be calculated using Cohen’s κ statistic.22 After
identifying the final number of studies to be included,
the overall precision of the searches will be calculated by
dividing the number of studies included by the total
number of studies screened after removing duplicates.23
The number needed-to-read will then be calculated as
the inverse of the precision.23 A flow diagram that
depicts the search process will be included as well as an
online supplementary file that includes a reference list
of all studies excluded, including the reason(s) for
exclusion. The proposed structure for the flow diagram
is shown in figure 1.
Data abstraction
Prior to the abstraction of data, a codebook that can
hold more than 200 items per study will be developed
using Microsoft Excel (Microsoft Excel (Version 2010).
Redmond, Washington: Microsoft Corporation, 2010).
The codebook will be developed by the first two authors
(GAK and KSK) with input from the third author
(LFC). The major categories of variables to be coded
will include: (1) study characteristics (author, journal,
year, etc.), (2) participant characteristics (age, height,
body weight, etc.), (3) intervention characteristics (type,
length, frequency, intensity, duration, compliance, etc.)
and (4) outcome characteristics for anxiety (sample
sizes, baseline and postexercise means and SDs, etc.).
The first two authors (GAK and KSK) will abstract the
data from all studies, independent of each other, using
separate codebooks in Microsoft Excel (Microsoft Excel
(Version 2010)). On completion of coding, the code-
books will be merged into one primary codebook for
review. Both authors will then meet and review all selec-
tions for agreement. Discrepancies will be resolved by
consensus. If consensus cannot be reached, the third
author (LFC) will provide a recommendation. Prior to
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correcting disagreements, the overall agreement rate will
be calculated using Cohen’s κ statistic.22
Outcomes and prioritisation
The primary outcome in this study will be changes in
anxiety. Secondary outcomes will include changes in
physical function, pain, quality of life, depression, body
mass index (BMI), aerobic fitness, and upper and lower
body strength.
Risk of bias assessment in individual studies
Risk of bias will be assessed at the study level using the
Cochrane risk of bias instrument,24 with a focus on the
primary outcome of interest, changes in anxiety. Bias
will be evaluated for six domains: (1) random sequence
generation, (2) allocation concealment, (3) blinding of
participants and personnel, (4) blinding of outcome
assessment, (5) incomplete outcome data, (6) selective
reporting, and (7) whether participants were exercising
regularly, as defined by the original study authors, prior
to taking part in the study. Each item will be classified as
having either a high, low or unclear risk of bias. In add-
ition, a text description of the basis for our judgement
in each of the seven domains will be provided. For
example, for a study rated as being at an unclear risk of
bias for the category of whether or not participants were
exercising regularly, we may provide a text description
such as ‘insufficient information provided to make a
decision’. Assessment for risk of bias will be limited to
the primary outcome of interest, that is, changes in
anxiety. Since it is virtually impossible to blind partici-
pants to group assignment in exercise intervention pro-
tocols, all studies will be classified as high risk of bias
with respect to the category ‘blinding of participants
and personnel’. On the basis of previous research, no
study will be excluded based on the results of the risk of
bias assessment.25 The first two authors (GAK and KSK)
will conduct all assessments, independent of each other.
Both authors will then meet and review all selections for
agreement. Discrepancies will be resolved by consensus.
Figure 1 Proposed flow diagram to depict the search process.
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If consensus cannot be reached, the third author (LFC)
will provide a recommendation.
Data synthesis
Calculation of effect sizes
The primary outcome for this proposed project will be
changes in anxiety, calculated as Hedge’s standardised
mean difference effect size (ES), adjusted for small-
sample bias.26 This will be calculated by subtracting the
change outcome difference in the exercise group minus
the change outcome difference in the control group,
and then dividing by the pooled SD of the change
outcome for the exercise and control groups. If change
score SDs are not available, these will be calculated from
reported change outcome or treatment effect 95% CIs
or pre-SD and post-SD values according to procedures
developed by Follmann et al.27 Secondary outcomes
(physical function, pain, quality of life, depression, BMI,
aerobic fitness, upper and lower body strength) will be
calculated using the same procedures as for our primary
outcome. For studies in which outcomes are assessed at
multiple time points, we plan on examining differences
between baseline values and the final time point closest
to cessation of the exercise intervention.
Pooled estimates for changes in outcomes
ES changes in anxiety and all secondary outcomes will
be pooled using the recently developed inverse hetero-
geneity (IVhet) model.28 The IVhet model is a quasi-
likelihood model that is computed by (1) calculating
weights that sum to 1 from each study, (2) pooling effects
from all the studies and (3) calculating the variance of
the pooled ES. The IVhet model has been shown to be
superior to the original random-effects, method-of-
moments model of Dersimonian and Laird,28 29 the
most common random-effects model used to pool aggre-
gate data meta-analytic results.29 Specifically, simulation
studies have shown that the IVhet model retains correct
coverage probabilities as well as a lower observed vari-
ance than the random-effects model, regardless of het-
erogeneity.28 Two-tailed z-α values <0.05 as well as
non-overlapping 95% CIs will be considered statistically
significant.
Heterogeneity and inconsistency for each pooled outcome
will be estimated using the Q30 and I2 statistic,31 respect-
ively. An α level of ≤0.10 for Q will be considered to rep-
resent statistically significant heterogeneity while
inconsistency will be categorised as very low (<25%), low
(25% to <50%), moderate (50% to <75%) or large (≥
75%).31 To improve practical relevance with respect to
potential improvements in anxiety and all secondary
outcomes, percentile gain in the exercise groups will be
calculated using Cohen’s U3 index
32 while the number-
needed-to treat (NNT) will be estimated.33
Derived from NNT, gross estimates will also be calcu-
lated for the number of adults with AORD in the USA
who may benefit from exercise but are not currently
meeting exercise recommendations. This will be based
on the reciprocal of the NNT multiplied by the number
of adults in the USA with doctor-diagnosed arthritis who
were not currently meeting exercise guidelines, currently
∼34.8 million.1 34
Influence analysis will be conducted with each study
deleted from the model once in order to examine the
effect of each study on our overall results. In addition,
cumulative meta-analysis, ranked by year, will be used to
examine the accumulation of results over time.
Meta-regression based on the IVhet model will be used
to examine the relationship between changes in our
primary outcome and selected covariates (table 1).28
Broadly, this will be accomplished by (1) conducting
simple meta-regression for statistically significant associa-
tions between selected covariates and changes in
anxiety, (2) examining for multicollinearity between cov-
ariates (r>0.80), and (3) building a multiple
meta-regression model (table 1). These models will use
a multiplicative versus additive component of residual
heterogeneity (Meta XL User Guide (Version 5.3).
Queensland, Australia: EpiGear International Pty Ltd,
2016). To achieve matching error variances, robust
Huber-Ecker-White-sandwich error variances will be
used to account for the underestimated dispersion
Table 1 Covariates to initially examine using simple meta-regression
Characteristics Variable
Study Publication year, impact factor of journal, country study conducted, type of control group, bias (sequence
generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessors,
incomplete outcome data, selective outcome reporting), type of analysis
Participant Age, gender, race/ethnicity, income, education, marital status, type of AORD, years since diagnosis of
AORD
Exercise Type (aerobic, strength, both), length, frequency, intensity, duration, total minutes, total minutes (adjusted
for compliance), mode, compliance, exercise supervision, setting, number of sets, number of repetitions,
rest between sets, number of exercises, type of resistance, equipment used, fidelity (design, training,
delivery, receipt, enactment)
Outcome Baseline values for anxiety, instrumentation, changes in physical function, changes in pain, changes in
quality of life, changes in depression, changes in BMI, changes in aerobic fitness, changes in upper body
strength, changes in lower body strength
AORD, arthritis and other rheumatic diseases; BMI, body mass index.
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(Meta XL User Guide (Version 5.3). 2016). Such errors
are expected to calculate the correct SEs for heteroge-
neous data that are traditionally heteroscedastic (Meta
XL User Guide (Version 5.3). 2016). For this study, con-
tinuous variables will be modelled as averages while cat-
egorical variables will be modelled as proportions.
Based on the recommendations of Rothman,35 no
adjustments for multiple testing will be made because of
concerns about missing possibly important findings that
could be pursued in future randomised controlled
trials.35 While this could be viewed as a ‘fishing exped-
ition’, such analyses are important for providing investi-
gators with potential direction for future randomised
controlled trials, one of the very reasons for conducting
a systematic review with meta-analysis. This approach is
especially appropriate for meta-analysis since covariates
are not randomly assigned in meta-analysis, and thus
such analyses are considered to be observational in
nature.36 As a result, causal inferences cannot be
derived from meta-regression. However, any observed
associations can provide direction for future research.
Thus, we consider our meta-regression analyses to be
exploratory in nature. The former notwithstanding, the
investigative team acknowledges that one or more statis-
tically significant associations may be nothing more than
chance findings.
Meta-biases
Small-study effects (publication bias, etc.) for primary and
secondary outcomes will be assessed following current
guidelines.37 This will include qualitative analysis using
funnel plots as well as quantitative analysis using Egger’s
regression-intercept test (one-tailed). Ninety-five per
cent CIs that do not include zero (0) will be considered
to represent statistically significant small-study effects.
Confidence in cumulative evidence
Strength of findings for our primary outcome (anxiety)
and all secondary outcomes (physical function, pain,
quality of life, depression, BMI, aerobic fitness, upper
and lower body strength) will be evaluated using the
Grading of Recommendations Assessment, Development
and Evaluation (GRADE) instrument for meta-analysis.38
The quality of evidence will be assessed across the
domains of risk of bias, consistency, directness, precision
and publication bias. Quality will be judged as high
(further research is very unlikely to change our confi-
dence in the estimate of effect), moderate (further
research is likely to have an important impact on our
confidence in the estimate of effect and may change the
estimate), low (further research is very likely to have an
important impact on our confidence in the estimate of
effect and is likely to change the estimate) or very low
(very uncertain about the estimate of effect). This will
be accomplished using the same procedures as for study
selection and data abstraction. Assessments will be con-
ducted following the same procedures as for the abstrac-
tion of data and risk of bias for individual studies.
Software used for data synthesis
All data will be analysed using Stata (V.14.1; Stata/SE for
Windows (Version 14.1). College Station, Texas: Stata
Corporation LP, 2015), Microsoft Excel 2010 (Microsoft
Excel (Version 2010)), and three add-ins for Excel, Meta
XL (V.5.3; Meta XL (Version 5.3). 2016), SSC-Stat
(V.2.18; SSC-Stat (Version 2.18). University of Reading,
UK: Statistical Services Center, 2007), and EZ-Analyze
(V.3.0; EZ Analyze (Version 3.0). Boston, MA: Tim
Poynton, 2007).
DISSEMINATION
The results of this study will be presented at a professional
conference and published in a peer-reviewed journal.
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